Alnylam Pharmaceuticals
ALNY
#625
Rank
NZ$55.49 B
Marketcap
$430.23
Share price
1.06%
Change (1 day)
43.46%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company